Lopetric 0.5mg Tablet DT
Marketer
Cubit Healthcare
Salt Composition
Haloperidol (0.5mg)
Overview Lopetric 0.5mg Tablet DT
Lopatric 0.5mg Delayed-Release Tablets treat schizophrenia, a mental illness characterized by distorted perceptions and behavior. Its mechanism involves inhibiting a neurotransmitter impacting mood and cognition. This medication also manages psychosis, manic episodes, and severe behavioral disturbances in adults and children. Administer as prescribed, with or without food, ideally at the same time daily for consistent blood levels. Missed doses should be taken promptly; complete the entire course regardless of symptom improvement. Abrupt cessation is unsafe and may exacerbate symptoms; consult your physician before discontinuing. Common side effects include restlessness, sleep difficulties, extrapyramidal symptoms, muscle stiffness, and headaches. Report any persistent or worsening side effects to your doctor, who can advise on mitigation strategies. Prior to treatment, disclose any thyroid, kidney, epilepsy, Parkinson's, glaucoma, or cardiac conditions. Avoid concurrent use with alcohol, sedatives, cough suppressants, or antihistamines. Weight gain is possible; maintain a healthy diet, limit high-calorie snacks, and exercise to minimize this risk.
Primary Ingredients of Lopetric 0.5mg Tablet DT
No information provided. Please provide the text you wish me to rephrase.
Uses of Lopetric 0.5mg Tablet DT
A chronic mental illness characterized by psychosis.
Major Benefits of Lopetric 0.5mg Tablet DT:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Always dissolve the Lopetric 0.5mg Tablet DT in water before consumption. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Lopetric 0.5mg Tablet DT:
- Agitation
- Extrapyramidal symptoms
- Insomnia (difficulty in sleeping)
- Muscle spasm
- Headache
How to use Lopetric 0.5mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Lopetric 0.5mg Tablet DT in water before consumption. While you can take it with or without food, consistent timing is recommended for optimal results.
How Lopetric 0.5mg Tablet DT works:
Lopetric 0.5mg Delayed-Release Tablets are a conventional antipsychotic medication. Their mechanism of action involves dopamine receptor antagonism, thereby modulating the effects of this neurotransmitter on cognitive function and emotional state.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Lopetric 0.5mg delayed-release tablets and alcohol can result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Lopetric 0.5mg Tablet DT during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Lopetric 0.5mg Tablet DT while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant. If this medication is necessary, careful observation of the baby for somnolence is recommended.
DrivingUNSAFE
Driving may be impaired by Lopetric 0.5mg Tablet DT, which can cause drowsiness, dizziness, and blurred vision. Refrain from operating a vehicle if such effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Lopetric 0.5mg Tablet DT is considered safe for individuals with kidney impairment; dose modification is generally unnecessary. Nevertheless, patients exhibiting severe kidney dysfunction might require an initiation dose reduction due to a potential increased risk of somnolence.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Lopetric 0.5mg Tablet DT; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Lopetric 0.5mg Tablet DT :
NA
Facts to Know About Lopetric 0.5mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Butyrophenone-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Class | Conventional Antipsychotics |
3,018 People bought this recently